Search - tctmd.com

Displaying 221 - 240 of 1522

Sort: Relevancy | Date

Presentation TCT 2024

TCT 204: Development and Validation of Artificial Intelligence-Based Algorithms for Predicting the Segments Debulked by Rotational Atherectomy Using Intravascular Ultrasound Images

Presenter: Kenta Hashimoto

October 27, 2024

Presentation TCT 2024

TCT 203: Artificial Intelligence-led Intracoronary OCT Analysis to Identify Drug Efficacy and Predict Patient Events

Presenter: NULL

October 27, 2024

Presentation TCT 2024

TCT 202: Diagnostic Performance of Artificial Intelligence-Derived Fractional Flow Reserve in Routine Clinical Practice: An International Multicenter Retrospective Study

Presenter: Eyal Ben-Assa

October 27, 2024

Presentation TCT 2024

TCT 201: Deep Learning-Based Segmentation of Coronary Arteries and Stenosis Detection in X-Ray Coronary Angiography: From Training to External Validation

Presenter: Elsa Hebbo

October 27, 2024

Presentation TCT 2024

TCT 200: Artificial Intelligence Detection of Retrograde Coronary Flow

Presenter: Hong Hieu Truong

October 27, 2024

Presentation TCT 2024

TCT 199: Left Ventricular Systolic Dysfunction Detection by Artificial Intelligence Enhanced 6-Lead Portable Electrocardiogram Device: A Prospective Single-Center Cohort Study

Presenter: Hak Seung Lee

October 27, 2024

Presentation TCT 2024

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

Presenter: Abhishek Chaturvedi

October 27, 2024

Presentation TCT 2024

TCT 678: Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

Presenter: Caïa Crooijmans

October 27, 2024

Presentation TCT 2024

TCT 677: Evaluating Ischemia With Nonobstructive Coronary Arteries Using Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presenter: Samit Shah

October 27, 2024

Presentation TCT 2024

TCT 676: Incidence of Coronary Microvascular Dysfunction in ANOCA Patients With and Without a History of Severe COVID-19 Infection: The COMET-19 Study

Presenter: TsungYing Tsai

October 27, 2024

Presentation TCT 2024

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

Presenter: Sant Kumar

October 27, 2024

Presentation TCT 2024

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

Presenter: Samit Shah

October 27, 2024

Presentation ESC 2024

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

Presenter: Ling Tao

September 02, 2024

Presentation ESC 2024

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Presenter: Manesh R. Patel

September 01, 2024

Presentation ESC 2024

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

Presenter: Gi-Byoung Nam

September 01, 2024

Presentation ESC 2024

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

Presenter: Jacob Lønborg

August 31, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

Advertisement

TCT 204: Development and Validation of Artificial Intelligence-Based Algorithms for Predicting the Segments Debulked by Rotational Atherectomy Using Intravascular Ultrasound Images

TCT 203: Artificial Intelligence-led Intracoronary OCT Analysis to Identify Drug Efficacy and Predict Patient Events

TCT 202: Diagnostic Performance of Artificial Intelligence-Derived Fractional Flow Reserve in Routine Clinical Practice: An International Multicenter Retrospective Study

TCT 201: Deep Learning-Based Segmentation of Coronary Arteries and Stenosis Detection in X-Ray Coronary Angiography: From Training to External Validation

TCT 200: Artificial Intelligence Detection of Retrograde Coronary Flow

TCT 199: Left Ventricular Systolic Dysfunction Detection by Artificial Intelligence Enhanced 6-Lead Portable Electrocardiogram Device: A Prospective Single-Center Cohort Study

TCT 679: Coronary Microvascular Dysfunction in Patients With Cancer Experiencing Angina With Nonobstructive Coronary Arteries

TCT 678: Angina Severity and Symptom Improvement Are Associated With Diagnostic Acetylcholine Provocation Dose in Vasospastic Angina

TCT 677: Evaluating Ischemia With Nonobstructive Coronary Arteries Using Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

TCT 676: Incidence of Coronary Microvascular Dysfunction in ANOCA Patients With and Without a History of Severe COVID-19 Infection: The COMET-19 Study

TCT 675: Assessment of Coronary Microvascular Dysfunction in Patients With Diabetes Mellitus Presenting With Angina With Nonobstructive Coronary Arteries

TCT 674: Diagnosis of Coronary Microvascular Dysfunction With Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry

DCB with rescue stenting versus intended stenting for de novo CAD: a multicenter, non-inferiority trial

OCEANIC-AF: Asundexian vs. Apixaban in Patients with Atrial Fibrillation

Edoxaban-Based Long-Term Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Disease: The EPIC-CAD Randomized Clinical Trial

NOTION-3: PCI in patients undergoing transcatheter aortic valve implantation

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Methodological Insight: REC-CAGEFREE II Trial

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content